Forma Therapeutics nabs new R&D execs as it plots late-stage sickle cell test next year

Heading into a pivotal year in 2021, Forma Therapeutics has hired two veterans out of Takeda and Incyte to help run its R&D programs.

The biotech, helmed by Genentech veteran Frank Lee, has been working on its transition from an early discovery and development company to one knocking on the door of approvals and commercialization.